McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
615.65
+0.05 (0.01%)
Nov 19, 2024, 4:00 PM EST - Market closed
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 299.25B | 283.29B | 278.74B | 271.63B | 260.54B | 250.83B | 240.62B | 232.62B | ||||||||||
| U.S. Pharmaceutical Growth | 14.86% | 12.94% | 15.84% | 16.77% | 15.42% | 14.49% | 9.83% | 9.50% | ||||||||||
| International | 14.59B | 14.35B | 14.13B | 13.95B | 14.76B | 17.52B | 20.60B | 25.77B | ||||||||||
| International Growth | -1.14% | -18.06% | -31.40% | -45.88% | -52.06% | -47.94% | -38.78% | -23.59% | ||||||||||
| Medical-Surgical Solutions | 11.45B | 11.34B | 11.31B | 11.17B | 11.12B | 11.13B | 11.11B | 11.30B | ||||||||||
| Medical-Surgical Solutions Growth | 2.99% | 1.88% | 1.83% | -1.15% | -2.38% | -4.65% | -4.81% | -1.86% | ||||||||||
| Prescription Technology Solutions | 4.89B | 4.77B | 4.77B | 4.77B | 4.69B | 4.57B | 4.39B | 4.23B | ||||||||||
| Prescription Technology Solutions Growth | 4.35% | 4.40% | 8.71% | 12.92% | 13.35% | 12.74% | 8.35% | 10.66% |
Operating Income by Segment
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Pharmaceutical | 3.22B | 2.74B | 2.79B | 2.49B | 3.03B | 3.34B | 3.21B | 3.14B | ||||||||||
| U.S. Pharmaceutical Growth | 6.20% | -17.89% | -13.10% | -20.54% | 0.17% | 15.35% | 10.82% | 1.39% | ||||||||||
| Prescription Technology Solutions | 774.00M | 807.00M | 835.00M | 813.00M | 771.00M | 653.00M | 566.00M | 539.00M | ||||||||||
| Prescription Technology Solutions Growth | 0.39% | 23.58% | 47.53% | 50.83% | 44.92% | 20.93% | 4.81% | 2.47% | ||||||||||
| Medical-Surgical Solutions | 758.00M | 913.00M | 952.00M | 973.00M | 1.03B | 1.09B | 1.12B | 1.16B | ||||||||||
| Medical-Surgical Solutions Growth | -26.62% | -16.08% | -14.77% | -16.34% | -9.62% | -4.56% | -2.02% | 12.80% | ||||||||||
| International | -222.00M | 352.00M | 319.00M | 292.00M | 302.00M | 199.00M | 136.00M | -114.00M | ||||||||||
| International Growth | - | 76.88% | 134.56% | - | - | - | - | - |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, Distribution, General, and Administrative | 9.20B | 8.79B | 8.66B | 8.43B | 7.83B | 7.69B | 7.78B | 8.34B | ||||||||||
| Selling, Distribution, General, and Administrative Growth | 17.50% | 14.32% | 11.33% | 1.07% | -17.98% | -25.11% | -24.24% | -16.21% | ||||||||||
| Claims and Litigation | 257.00M | 259.00M | 147.00M | - | -6.00M | - | -8.00M | 76.00M | ||||||||||
| Claims and Litigation Growth | - | - | - | - | - | - | - | -38.71% | ||||||||||
| Restructuring, Impairment, and Other | 216.00M | 73.00M | 115.00M | 209.00M | 236.00M | 238.00M | 209.00M | 157.00M | ||||||||||
| Restructuring, Impairment, and Other Growth | -8.47% | -69.33% | -44.98% | 33.12% | 63.89% | 63.01% | 43.15% | 15.44% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.